Induced pluripotent stem cell for modeling Pompe disease.

Area of Science:

• Biochemistry
• Genetics
• Stem Cell Biology

Background:

• Pompe disease (PD) is a rare, inherited metabolic disorder.
• It results from a defect in lysosomal alpha-glucosidase, leading to glycogen buildup.
• Key symptoms include hypertrophic cardiomyopathy, muscle weakness, and hepatomegaly.

Purpose of the Study:

• To review advancements in Pompe disease modeling using induced pluripotent stem cells (iPSCs).
• To highlight how iPSCs overcome limitations in previous disease modeling.
• To discuss the application of iPSC-based models in understanding PD mechanisms and drug development.

Main Methods:

• Utilizing induced pluripotent stem cell (iPSC) reprogramming technology.
• Developing patient-specific cell models for Pompe disease.
• Employing these models for disease mechanism exploration and drug screening.

Main Results:

• iPSC technology provides effective cell models for Pompe disease research.
• These models facilitate detailed investigation of PD pathogenesis.
• iPSC-derived cells are valuable for drug screening and toxicity assessments.

Conclusions:

• Induced pluripotent stem cells represent a significant advancement for Pompe disease research.
• iPSC technology enables robust disease modeling and mechanism elucidation.
• This approach holds promise for developing novel therapies and improving patient outcomes.